Showing 1 - 19 results of 19 for search 'Seth M Pollack', query time: 0.07s
Refine Results
-
1
-
2
Trabectedin in Soft Tissue Sarcomas by Bradley J. Petek, Elizabeth T. Loggers, Seth M. Pollack, Robin L. Jones
Published 2015-02-01
Article -
3
-
4
Response to PD1 inhibition in conventional chondrosarcoma by Michael J. Wagner, Robert W. Ricciotti, Jose Mantilla, Elizabeth T. Loggers, Seth M. Pollack, Lee D. Cranmer
Published 2018-09-01
Article -
5
-
6
-
7
-
8
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. by Seth M Pollack, Yonqing Li, Megan J Blaisdell, Erik A Farrar, Jeffrey Chou, Benjamin L Hoch, Elizabeth T Loggers, Eve Rodler, Janet F Eary, Ernest U Conrad, Robin L Jones, Cassian Yee
Published 2012-01-01
Article -
9
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin by Jiyong Liang, Dexing Fang, Joy Gumin, Hinda Najem, Moloud Sooreshjani, Renduo Song, Aria Sabbagh, Ling-Yuan Kong, Joseph Duffy, Irina V. Balyasnikova, Seth M. Pollack, Vinay K. Puduvalli, Amy B. Heimberger
Published 2023-02-01
Article -
10
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment. by Kendall C Shibuya, Vikas K Goel, Wei Xiong, Jonathan G Sham, Seth M Pollack, Allison M Leahy, Samuel H Whiting, Matthew M Yeh, Cassian Yee, Stanley R Riddell, Venu G Pillarisetty
Published 2014-01-01
Article -
11
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma by Victor M. Villalobos, Gary Mo, Mark Agulnik, Seth M. Pollack, Daniel A. Rushing, Arun Singh, Brian A. Van Tine, Rhian McNaughton, Rodney L. Decker, Wei Zhang, Ashwin Shahir, Damien M. Cronier
Published 2020-02-01
Article -
12
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States by Seth M. Pollack, Neeta Somaiah, Dejka M. Araujo, Mihaela Druta, Brian A. Van Tine, Melissa A. Burgess, Sant P. Chawla, Mahesh Seetharam, Scott H. Okuno, Chet Bohac, Michael Chen, Sergey Yurasov, Steven Attia
Published 2020-07-01
Article -
13
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients by Brett A. Schroeder, Yuzheng Zhang, Kimberly S. Smythe, Parth Desai, Anish Thomas, Pedro Viveiros, Borislav A. Alexiev, Farres Obeidin, Eleanor Y. Chen, Lee D. Cranmer, Michael J. Wagner, Robin L. Jones, Jean S. Campbell, Robert H. Pierce, Qianchuan He, Seth M. Pollack
Published 2022-03-01
Article -
14
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond by Surya Pandey, Meghan E. Cholak, Rishita Yadali, Jeffrey A. Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M. Pollack, Sacha Gnjatic, Rebecca C. Obeng, H. Kim Lyerly, Adam M. Sonabend, José A. Guevara-Patiño, Lisa H. Butterfield, Bin Zhang, Holden T. Maecker, I. Caroline Le Poole
Published 2024-01-01
Article -
15
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN) by Bernd Kasper, Annie Achee, Kathrin Schuster, Roger Wilson, Gerard van Oortmerssen, Rebecca A. Gladdy, Matthew L. Hemming, Paul Huang, Matthew Ingham, Robin L. Jones, Seth M. Pollack, Denise Reinke, Roberta Sanfilippo, Scott M. Schuetze, Neeta Somaiah, Brian A. Van Tine, Breelyn Wilky, Scott Okuno, Jonathan Trent
Published 2021-02-01
Article -
16
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or... by Neeta Somaiah, Sant P. Chawla, Matthew S. Block, John C. Morris, Khanh Do, Joseph W. Kim, Mihaela Druta, Kamalesh K. Sankhala, Patrick Hwu, Robin L. Jones, Sacha Gnjatic, Seunghee Kim-Schulze, Kevin Tuballes, Mahlet Yishak, Hailing Lu, Adam Yakovich, Jan Ter Meulen, Michael Chen, Richard T. Kenney, Chet Bohac, Seth M. Pollack
Published 2020-01-01
Article -
17
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma by Matthew B. Spraker, MD, PhD, Landon S. Wootton, PhD, Daniel S. Hippe, MS, Kevin C. Ball, MD, Jan C. Peeken, MD, Meghan W. Macomber, MD, Tobias R. Chapman, MD, Michael N. Hoff, PhD, Edward Y. Kim, MD, Seth M. Pollack, MD, Stephanie E. Combs, MD, Matthew J. Nyflot, PhD
Published 2019-04-01
Article -
18
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment by Kenneth R. Gundle, Kenneth R. Gundle, Karthik Rajasekaran, Jeffrey Houlton, Gary B. Deutsch, Thomas J. Ow, Thomas J. Ow, Robert G. Maki, Robert G. Maki, John Pang, Cherie-Ann O. Nathan, Daniel Clayburgh, Daniel Clayburgh, Jason G. Newman, Elyse Brinkmann, Michael J. Wagner, Seth M. Pollack, Seth M. Pollack, Matthew J. Thompson, Ryan J. Li, Vikas Mehta, Bradley A. Schiff, Barry I. Wenig, Paul L. Swiecicki, Alice L. Tang, Jessica L. Davis, Annemieke van Zante, Jessica A. Bertout, Wendy Jenkins, Atticus Turner, Marc Grenley, Connor Burns, Jason P. Frazier, Angela Merrell, Kimberly H. W. Sottero, Jonathan M. J. Derry, Kate C. Gillespie, Bre Mills, Richard A. Klinghoffer
Published 2024-04-01
Article -
19
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes by Seth M Pollack, Robin L Jones, Marissa Vignali, Brett A Schroeder, Shihong Zhang, Jose G Mantilla, Kimberly S Smythe, Jean S Campbell, Robert H Pierce, Lee D Cranmer, Michael J Wagner, Bonnie J LaFleur, Brian C Schulte, Natalie A LaFranzo, Rachel M Gittelman, Kevin C Flanagan, Julie Rytlewski, Laura Riolobos, Teresa S Kim, Eleanor Chen
Published 2021-08-01
Article